短期治疗延迟对肺癌存活率没有可检测的影响
Zoltan Ungvari1,2,3,4,5, Mónika Fekete6,7,8, Annamaria Buda6,7,9
1Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
GeroScience
|May 7, 2025
概括
开始肺癌治疗的短暂延迟,长达12周,不会显著影响患者的存活率. 这一元分析表明,针对侵袭性癌症的严格时间表,个人化护理比严格的时间表更为重要.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 生物统计学 生物统计学
背景情况:
- 及时启动治疗对于像肺癌这样的侵袭性癌症至关重要.
- 短期治疗延迟对肺癌存活率的影响尚未得到充分证实.
研究的目的:
- 评估治疗延迟4周,8周和12周与肺癌患者全因死亡率之间的关联.
- 为了确定肺癌治疗的短期延迟是否会影响生存结果.
主要方法:
- 在PubMed,Scopus和Web of Science (2000-2025) 的系统文献搜索.
- 用随机效应模型估计危险比率 (HRs) 的15项研究 (16个队列) 的元分析.
- 评估异质性 (I2统计) 和出版偏差 (漏斗图,埃格尔测试).
主要成果:
- 治疗延迟 (4,8或12周) 与全因死亡率之间没有发现显著的关联.
- 延迟的汇总HR为1.00 (95%CI,0.99-1.02) 长达4周,1.01 (95%CI,0.99-1.03) 长达8周,以及1.01 (95%CI,0.98-1.05) 长达12周.
- 观察到高异质性 (I2=97%),但没有发现出版偏差.
结论:
- 短期治疗延迟 (长达12周) 并没有显著影响肺癌患者的死亡率.
- 这些发现挑战了短暂的延迟总是会使结果变得更糟的假设.
- 强调在肺癌护理中个性化治疗规划和优先考虑的重要性.
相关概念视频
01:21Cancer Survival Analysis
291
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
291
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
01:28Pulmonary Tuberculosis V
145
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
145
01:15Assumptions of Survival Analysis
56
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
56